These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surveillance of Drug-Resistant Tuberculosis in Spain (2001-2015). Gutiérrez-Aroca JB; Ruiz P; Vaquero M; Causse M; Casal M Microb Drug Resist; 2018; 24(6):839-843. PubMed ID: 29608388 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems. Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195 [TBL] [Abstract][Full Text] [Related]
4. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. El-Sayed Zaki M; Goda T Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089 [TBL] [Abstract][Full Text] [Related]
5. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002). Negi SS; Gupta S; Lal S J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952 [TBL] [Abstract][Full Text] [Related]
6. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [TBL] [Abstract][Full Text] [Related]
7. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998. Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700 [TBL] [Abstract][Full Text] [Related]
8. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985 [TBL] [Abstract][Full Text] [Related]
9. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains]. Kobayashi I; Abe C; Mitarai S Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006 [TBL] [Abstract][Full Text] [Related]
10. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy. Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318 [TBL] [Abstract][Full Text] [Related]
11. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231 [TBL] [Abstract][Full Text] [Related]
12. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens]. Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157 [TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of the action of drugs in the short-course chemotherapy]. Mitchison DA Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374 [No Abstract] [Full Text] [Related]
14. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. Dickinson JM; Aber VR; Mitchison DA Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953 [TBL] [Abstract][Full Text] [Related]
16. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793 [TBL] [Abstract][Full Text] [Related]
17. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Al-Marri MR Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769 [TBL] [Abstract][Full Text] [Related]
18. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966 [TBL] [Abstract][Full Text] [Related]
19. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987. Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]